BPDO-1603 Intervention Trial in Patients With Moderate-to-severe Alzheimer's Disease
Clinical trial NCT04229927 · UNKNOWN
Trial details
- NCT number
- NCT04229927
- Sponsor
- Hyundai Pharmaceutical Co., LTD.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-27
- Primary completion
- 2022-02-28
- Enrollment
- 712
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.